Centene


At a Glance

  • Revenues and EBIDTA down slightly from previous reporting quarter
  • Price decrease using both month close analysis and moving average
  • Hiring up substantially versus sector for August
  • Regulatory approvals for WellCare deal 2/3rds done (at state level)

Rolling 12 months financials

Year over year financials


Stock Performance

MA= Moving average; GSPC= S&P 500

Analyst buy/sell recommendations

Insider sentiment for quarter- Neutral

Based on trading behaviors of company officers and directors trading in their own stock


Earnings Call Summary

No call transcript available at time of writing 


Other indicators

Innovation score - Underperforming sector

Based on R&D activities. 


Deeper reading



END OF REPORT

x